Biocon Opens US Manufacturing Facility in New Jersey

1 Minute Read Listen to Article
Share:    

Sep 11, 2025 13:47

x
Biocon inaugurates its first US manufacturing plant in Cranbury, New Jersey. A USD 30 million investment for oral solid dosage production.
Biocon Opens US Manufacturing Facility in New Jersey
New Delhi, Sep 11 (PTI) Biocon Ltd on Thursday said it has inaugurated its first manufacturing facility in the US, located in Cranbury, New Jersey.

The company's wholly-owned subsidiary, Biocon Generics Inc. (BGI), operates the plant.

Biocon acquired the Oral Solid Dosage (OSD) facility from Eywa Pharma Inc in 2023 and has since invested over USD 30 million to establish a plant with an annual production capacity of 2 billion tablets.


A few products have already been commercialised from the site, with several more in the pipeline, the Bengaluru-based firm said in a statement.

This investment helps Biocon diversify its manufacturing base, strengthen its supply chain and accelerate the expansion of its global footprint, it added.

"Biocon's first USFDA-approved formulations facility in New Jersey marks a new chapter in our journey of global expansion," Kiran Mazumdar-Shaw, Chairperson of Biocon Group, said.

The facility reflects the company's long-term commitment to deeper engagement with healthcare providers, innovators, and communities to build a healthier and equitable future, she added.
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback